Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comorbidity With Greatest Impact on Mortality Considering Different Admission Diagnosis and After Landmark Time in an Intensive Care Population Compared to the General Population

NCT06234709 is registered in ClinicalTrials.gov with Anna Aronsson as lead sponsor.

NCT NCT06234709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06234709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comorbidity With Greatest Impact on Mortality Considering Different Admission Diagnosis and After Landmark Time in an Intensive Care Population Compared to the General Population
Lead sponsor
Anna Aronsson
Phase
Observational
Overall status
Completed
Start date
January 1, 2005
Completion date
December 31, 2016
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical care